Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2025-07-01 00:00:00 ET · period of report 2025-06-30 · accession 0001415889-25-018748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-01 | 2025-06-30 | VTGN | Singh Shawn | Pres, CEO, Dir | A - Grant | $1.70 | +7,541 | 18.0K | +72% | +$12.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-30 | A | A | 7,541 | $1.70 | 18,028 | D | — | — |